DNS - Enoxaparin II
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| D2286/2023-ÚVN | 18. 10. 2023 | PROMEDICA PRAHA GROUP, a.s. | 11 816 164,80 | 10 741 968,00 | 11 816 164,80 | 10 741 968,00 | CZK | |
| S-002119/23 | 13. 10. 2023 | PROMEDICA PRAHA GROUP, a.s. | 4 598 007,92 | 4 180 007,20 | 4 598 007,92 | 4 180 007,20 | CZK | |
| 2-186/2023-1470 | 12. 10. 2023 | PROMEDICA PRAHA GROUP, a.s. | 3 833 638,16 | 3 485 125,60 | 3 833 638,16 | 3 485 125,60 | CZK |
Published Documents
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| sanofi-aventis, s.r.o. | Praha | 20 742 764,24 | 18 857 058,40 | CZK | ||
| PROMEDICA PRAHA GROUP, a.s. | Praha | 20 247 810,88 | 18 407 100,80 | CZK |
Price Actually Paid in Each Year of Performance
| 2-186/2023-1470 | 2023 | 267 764,74 | 242 004,75 |
| S-002119/23 | 2023 | 357 123,80 | 324 657,68 |
| 1989/2023-SML | 2023 | 36 937,12 | 33 579,20 |